Prevatt Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.3M Buy
214,000
+52,000
+32% +$14.4M 10.25% 3
2026
Q1
$47.8M Hold
162,000
12.89% 2
2025
Q4
$44.2M Hold
162,000
12.8% 3
2025
Q3
$43.8M Hold
162,000
14.88% 2
2025
Q2
$44.7M Buy
162,000
+12,000
+8% +$3.26M 15.32% 2
2025
Q1
$39.8M Hold
150,000
13.1% 2
2024
Q4
$34.8M Hold
150,000
10.03% 3
2024
Q3
$33.1M Buy
150,000
+35,000
+30% +$7.24M 10.89% 3
2024
Q2
$22.6M Buy
115,000
+5,000
+5% +$1.03M 7.05% 10
2024
Q1
$23.7M Hold
110,000
7.99% 5
2023
Q4
$23.2M Buy
+110,000
New +$23.5M 8.56% 5

Other funds holding CME

Prevatt Capital's CME Position: Q2 2026 in Review

Prevatt Capital increased its CME Group (CME) stake by 32% in Q2 2026, buying an estimated $14.4M and bringing the position to 214,000 shares worth $47.3M. The position accounts for 10.25% of the portfolio, ranked #3.

Prevatt Capital first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $47.8M in Q1 2026. 1,707 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Prevatt Capital held 214,000 shares of CME Group worth $47.3M as of Q2 2026.
  • Prevatt Capital bought 52,000 CME Group shares in Q2 2026, an estimated $14.4M.
  • CME Group made up 10.25% of Prevatt Capital's portfolio in Q2 2026, its #3 holding.
  • Prevatt Capital first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Prevatt Capital's CME Group position peaked at $47.8M in Q1 2026.
  • 1,707 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Prevatt Capital's 13F filing for Q2 2026, filed 14 Aug 2026.